Pregnancy planning and folic acid supplement use

Results from a survey in Quebec

Pascale Morin, Philippe De Wals, Manon Noiseux, Théophile Niyonsenga, Denise St-Cyr-Tribble, Claude Tremblay

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background. To decrease the risk of neural tube defects, all women planning pregnancy or capable of becoming pregnant should take folic acid supplements. The aim of the study was to describe the association between pregnancy planning and vitamin supplement use. Methods. A total of 1,858 pregnant women registered for a prenatal ultrasound examination in the Montérégie region, Province of Quebec, Canada, completed a questionnaire between November 1997 and May 1998. Pregnancy planning was described by six ordinal variables, which were included in a nonlinear principal component analysis. The main dimension representing the intensity of pregnancy planning was used as the dependent variable in a multivariate linear regression model, and as a basis for assessing vitamin use according to four levels of planning. Results. A majority of women scored high for intensity of pregnancy planning. Planning intensity score increased with age and was higher among women who attended university, had a family income greater than CAD $30,000, and were married. Vitamin use in the period prior to conception occurred with a frequency of 27.5%, increasing moderately with planning intensity scores. Overall, only 13.5% of fetuses were exposed to adequate doses of folic acid. Conclusion. A promotion campaign selectively targeting women likely to plan a pregnancy could have a significant impact in reducing neural tube defect incidence.

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalPreventive Medicine
Volume35
Issue number2
DOIs
Publication statusPublished - 1 Jan 2002
Externally publishedYes

Fingerprint

Quebec
Folic Acid
Pregnancy
Vitamins
Neural Tube Defects
Linear Models
Principal Component Analysis
Canada
Surveys and Questionnaires
Pregnant Women
Fetus
Incidence

Cite this

Morin, Pascale ; De Wals, Philippe ; Noiseux, Manon ; Niyonsenga, Théophile ; St-Cyr-Tribble, Denise ; Tremblay, Claude. / Pregnancy planning and folic acid supplement use : Results from a survey in Quebec. In: Preventive Medicine. 2002 ; Vol. 35, No. 2. pp. 143-149.
@article{fc73ad3c3358403b91109b19728b27b3,
title = "Pregnancy planning and folic acid supplement use: Results from a survey in Quebec",
abstract = "Background. To decrease the risk of neural tube defects, all women planning pregnancy or capable of becoming pregnant should take folic acid supplements. The aim of the study was to describe the association between pregnancy planning and vitamin supplement use. Methods. A total of 1,858 pregnant women registered for a prenatal ultrasound examination in the Mont{\'e}r{\'e}gie region, Province of Quebec, Canada, completed a questionnaire between November 1997 and May 1998. Pregnancy planning was described by six ordinal variables, which were included in a nonlinear principal component analysis. The main dimension representing the intensity of pregnancy planning was used as the dependent variable in a multivariate linear regression model, and as a basis for assessing vitamin use according to four levels of planning. Results. A majority of women scored high for intensity of pregnancy planning. Planning intensity score increased with age and was higher among women who attended university, had a family income greater than CAD $30,000, and were married. Vitamin use in the period prior to conception occurred with a frequency of 27.5{\%}, increasing moderately with planning intensity scores. Overall, only 13.5{\%} of fetuses were exposed to adequate doses of folic acid. Conclusion. A promotion campaign selectively targeting women likely to plan a pregnancy could have a significant impact in reducing neural tube defect incidence.",
keywords = "Folic acid, Health promotion, Neural tube defect, Pregnancy planning, Vitamin",
author = "Pascale Morin and {De Wals}, Philippe and Manon Noiseux and Th{\'e}ophile Niyonsenga and Denise St-Cyr-Tribble and Claude Tremblay",
year = "2002",
month = "1",
day = "1",
doi = "10.1006/pmed.2002.1041",
language = "English",
volume = "35",
pages = "143--149",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "2",

}

Morin, P, De Wals, P, Noiseux, M, Niyonsenga, T, St-Cyr-Tribble, D & Tremblay, C 2002, 'Pregnancy planning and folic acid supplement use: Results from a survey in Quebec', Preventive Medicine, vol. 35, no. 2, pp. 143-149. https://doi.org/10.1006/pmed.2002.1041

Pregnancy planning and folic acid supplement use : Results from a survey in Quebec. / Morin, Pascale; De Wals, Philippe; Noiseux, Manon; Niyonsenga, Théophile; St-Cyr-Tribble, Denise; Tremblay, Claude.

In: Preventive Medicine, Vol. 35, No. 2, 01.01.2002, p. 143-149.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pregnancy planning and folic acid supplement use

T2 - Results from a survey in Quebec

AU - Morin, Pascale

AU - De Wals, Philippe

AU - Noiseux, Manon

AU - Niyonsenga, Théophile

AU - St-Cyr-Tribble, Denise

AU - Tremblay, Claude

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background. To decrease the risk of neural tube defects, all women planning pregnancy or capable of becoming pregnant should take folic acid supplements. The aim of the study was to describe the association between pregnancy planning and vitamin supplement use. Methods. A total of 1,858 pregnant women registered for a prenatal ultrasound examination in the Montérégie region, Province of Quebec, Canada, completed a questionnaire between November 1997 and May 1998. Pregnancy planning was described by six ordinal variables, which were included in a nonlinear principal component analysis. The main dimension representing the intensity of pregnancy planning was used as the dependent variable in a multivariate linear regression model, and as a basis for assessing vitamin use according to four levels of planning. Results. A majority of women scored high for intensity of pregnancy planning. Planning intensity score increased with age and was higher among women who attended university, had a family income greater than CAD $30,000, and were married. Vitamin use in the period prior to conception occurred with a frequency of 27.5%, increasing moderately with planning intensity scores. Overall, only 13.5% of fetuses were exposed to adequate doses of folic acid. Conclusion. A promotion campaign selectively targeting women likely to plan a pregnancy could have a significant impact in reducing neural tube defect incidence.

AB - Background. To decrease the risk of neural tube defects, all women planning pregnancy or capable of becoming pregnant should take folic acid supplements. The aim of the study was to describe the association between pregnancy planning and vitamin supplement use. Methods. A total of 1,858 pregnant women registered for a prenatal ultrasound examination in the Montérégie region, Province of Quebec, Canada, completed a questionnaire between November 1997 and May 1998. Pregnancy planning was described by six ordinal variables, which were included in a nonlinear principal component analysis. The main dimension representing the intensity of pregnancy planning was used as the dependent variable in a multivariate linear regression model, and as a basis for assessing vitamin use according to four levels of planning. Results. A majority of women scored high for intensity of pregnancy planning. Planning intensity score increased with age and was higher among women who attended university, had a family income greater than CAD $30,000, and were married. Vitamin use in the period prior to conception occurred with a frequency of 27.5%, increasing moderately with planning intensity scores. Overall, only 13.5% of fetuses were exposed to adequate doses of folic acid. Conclusion. A promotion campaign selectively targeting women likely to plan a pregnancy could have a significant impact in reducing neural tube defect incidence.

KW - Folic acid

KW - Health promotion

KW - Neural tube defect

KW - Pregnancy planning

KW - Vitamin

UR - http://www.scopus.com/inward/record.url?scp=0036389562&partnerID=8YFLogxK

U2 - 10.1006/pmed.2002.1041

DO - 10.1006/pmed.2002.1041

M3 - Article

VL - 35

SP - 143

EP - 149

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 2

ER -